Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 18, 2025 10:10 ET | Source: Research and Markets

Hemophilia B Research Report 2025-2035: Market Led by UniQure, Pfizer, Novo Nordisk, HEMA Biologics, and Alnylam Pharmaceuticals as Next-Generation Therapies and R&D Investment Drive Innovation

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Hemophilia B Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...
October 22, 2025 11:57 ET | Source: Spherix Global Insights

Hemophilia Specialists Raise the Bar: Quality of Life and Innovation Drive Market Reordering

EXTON, PA, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Hematologists across the United States are redefining what “success” looks like in hemophilia treatment, according to the latest findings from Market...
October 09, 2025 04:50 ET | Source: Research and Markets

Bleeding Disorder Diagnostics Market Global Forecast 2025-2032: Key Opportunities Through Digital Integration, AI-driven Analytics, and Expanded Point-of-care Testing

Dublin, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The "Bleeding Disorder Diagnostics Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. Valued at USD 710.26...
February 18, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Hemophilia Market Insights: Key Trends and Developments Across Different Types of Hemophilia | DelveInsight

New York, USA, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Hemophilia Market Insights: Key Trends and Developments Across Different Types of Hemophilia | DelveInsight The hemophilia market is expected to...
February 06, 2025 06:07 ET | Source: Research and Markets

Blood Plasma Derivatives Market Insights and Forecast 2025-2030 - Grifols, SK Plasma, and Fusion Health Care Lead the Competition

Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The "Blood Plasma Derivatives Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type"...
January 13, 2025 11:18 ET | Source: Research and Markets

$15.7 Bn Haemophilia Treatment Market - Global Industry Trends Opportunities, and Forecasts, 2020-2030

Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Haemophilia Treatment Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F" report has been added to ...
November 25, 2024 07:30 ET | Source: FACT.MR

Hemophilia B Treatment Market Surges with 7.6% CAGR, set to Hit $8.97 Billion by 2034 | Fact.MR Report

Rockville, MD, Nov. 25, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global Hemophilia B treatment market is estimated to reach a...
November 21, 2024 09:27 ET | Source: Spherix Global Insights

Patient Chart Audit Reveals Changing Paroxysmal Nocturnal Hemoglobinuria (PNH) Market Dynamics As New Competition Challenges Alexion/Astra Zeneca's Soliris and Ultomiris

EXTON, PA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights has released its first annual chart audit study in hematology, Patient Chart Dynamix™ : Paroxysmal Nocturnal Hemoglobinuria (PNH)...
October 14, 2024 12:33 ET | Source: Spherix Global Insights

Hemophilia Markets Poised for Evolution as Competitive Dynamics between Hemlibra (Roche/Genentech) and Altuviiio (Sanofi) Intensify and Hympavzi (Pfizer) Receives Approval, According to Spherix Global Insights

EXTON, PA, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Hemophilia, a genetic disorder that impairs blood clotting, affects thousands of people worldwide. The treatment landscape is rapidly evolving, fueled by...
March 27, 2024 13:00 ET | Source: DelveInsight Business Research LLP

Hemophilia B Drug Market Size and Share to Grow by 2032, Assesses DelveInsight | Key Emerging Therapies - CSL222, SerpinPC, AskBio009, PF-06838435/fida, Marstacimab, FLT180a, Concizumab, Fitusiran

New York, USA, March 27, 2024 (GLOBE NEWSWIRE) -- Hemophilia B Drug Market Size and Share to Grow by 2032, Assesses DelveInsight | Key Emerging Therapies - CSL222, SerpinPC, AskBio009,...